Vir Biotechnology, Inc. VIR Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s shares (basic)?
- Vir Biotechnology, Inc. (VIR) reported shares (basic) of 147.4M in Q1 2026.
- How has Vir Biotechnology, Inc.'s shares (basic) changed year-over-year?
- Vir Biotechnology, Inc.'s shares (basic) increased by 7.2% year-over-year, from 137.5M to 147.4M.
- What is the long-term trend for Vir Biotechnology, Inc.'s shares (basic)?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s shares (basic) has grown at a 1.6% compound annual growth rate (CAGR), from 518.4M to 553.4M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.